HIV PREVENTION UPON TRANSFUSION OF DONATED BLOOD AND BLOOD COMPONENTS
https://doi.org/10.22328/2077-9828-2014-6-4-64-68
Abstract
Data about the rates of HIV marker detection in donated blood and its components in the Russian Federation in 2009-2013 are presented. The use of in-procedure methods of ensuring blood and blood products safety, which are executable upon blood transfusion to exclude HIV transmission, is discussed. The rate of detecting of HIV markers in blood donors varied within 0,09-0,12% over the observation period. In 2009-2013, the amount of quarantined plasma delivered by Russian Blood Service increased 1,4-fold, the amount of stored plasma treated to deactivate viruses increased 3-fold, and the proportion of platelet concentrate treated to inactivate viruses increased 3,8-fold. The degrees of implementing modern technologies of ensuring donated blood safety show high interregional variability.
About the Authors
A. V. Chechetkin
Research Institute of Hematology and Blood Transfusion
Russian Federation
Russian Federation
A. B. Makeyev
Research Institute of Hematology and Blood Transfusion
Russian Federation
Russian Federation
V. Ye. Soldatenkov
Research Institute of Hematology and Blood Transfusion
Russian Federation
Russian Federation
V. V. Danilchenko
Research Institute of Hematology and Blood Transfusion
Russian Federation
Russian Federation
M. Sh. Grigor’Yan
Research Institute of Hematology and Blood Transfusion
Russian Federation
Russian Federation
References
1. Литманович К.Ю., Селиванов Е.А., Дуткевич И.Г., Солдатенков В.Е. Проблемы безопасности и эффективности гемотрансфузионной терапии // Эфферентная терапия.- 2004.- № 3.- С. 37-47.
2. Коденев А.Т., Губанова М.Н., Жибурт Е.Б. Скрининг маркеров инфекций у доноров крови // Вестн. службы крови России.- 2010.- № 2.- С. 13-16.
3. Селиванов Е.А., Данилова Т.Н., Дегтерева И.Н., Григорьян М.Ш. Обеспечение инфекционной безопасности гемотрансфузий в Российской Федерации // ВИЧ-инфекция и иммуносупрессии.- 2009. - № 1. - С. 62-67.
4. van Hoeven L.R., Janssen M.P., Rautmann G. The collection, testing and use of blood and blood components in Europe. 2011 report // Directorate for the quality of medicines and healthcare of the Council of Europe (EDQM).- 2014.- 64 р.
5. Sonmezoglu М. Blood safety improvements after centralisation and challenges during the process // Vox Sang.- 2013.- Vol. 105, Suppl. 1.- P. 66.
6. Farouk B.R. Safety of VNRBDS versus family replacement blood donors in Egypt, evidence based approach // Vox Sang.- 2013.- Vol. 105, Suppl. 1.- P. 104
7. Sharma R.R., Dhawan H.K., Sachdev S., Marwaha N. Prevalence and trends of infectious markers and co-infection of transfusion transmitted diseases in north Indian blood donors (1999-2010) // Vox Sang.- 2011.- Vol. 101, Suppl. 1.- P 196.
8. Muller-Breitkreutz K., Mohr H. Hepatitis C and human immunodeficiency virus RNA degradation by methylene blue/light treatment of human plasma // J. Med. Virol.- 1998.- Vol. 56, № 3.- Р 239-245.
9. Irsch J., Lin L. Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood System // Transfus. Med. Hemother.- 2011.- Vol. 38.- Р 19-31.
10. Goodrich R.P., Edrich R.P., Li J., Seghatchian J. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends // Transf. Apheres. Sci.- 2006.- Vol. 35, № 1.- Р 5-17.
11. Lozano M., Cazenave J.-P., Braunig B., Behr-Gross M.-E. Implementation of pathogen reduction technologies for blood components for transfusion: updated table 2009-2010 / European committee (partial agreement) on blood transfusion (CD-P-TS).- Strasbourg, EDQM, 2013.- 4 p.
12. Reddy L., Marschner S., Doane S. Room temperature storage of whole blood treated with the Mirasol system // Vox. Sang.- 2010.- Vol. 99, Suppl. 1.- Р 243-244.
13. Brixner V., Leibacher J., Janetzko K. Validation of the S-303 pathogen inactivation system for RBC components // Vox Sang.- 2013.- Vol. 105, Suppl. 1.- P 145.
14. Белякова В.В., Гукасян И.А., Момотюк К.С., Майорова О.А., Кузнецов О.Е., Дашкова Н.Г., Рагимов А.А. Генотестирование доноров на гемотрансмиссивные инфекции // Вестн. службы крови России.- 2012.- № 1.- С. 9-12.
Review
For citations:
Chechetkin A.V., Makeyev A.B., Soldatenkov V.Ye., Danilchenko V.V., Grigor’Yan M.Sh. HIV PREVENTION UPON TRANSFUSION OF DONATED BLOOD AND BLOOD COMPONENTS. HIV Infection and Immunosuppressive Disorders. 2014;6(4):64-68. (In Russ.) https://doi.org/10.22328/2077-9828-2014-6-4-64-68
Views:
805
.png)
Email this article 